Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
53 Cards in this Set
- Front
- Back
What is anemia?
|
- "Without blood"- reduced number of RBCs, Hb, and/or Hct.
- Decreased oxygen delivery. - Not a dz; manifestation of numerous other underlying processes. - Most common manifestation of dz worldwide. |
|
Hb Reference Value
|
Female: 12.0-15.0 g/dL
Male: 14.0-18.0 g/dL |
|
Hct Reference Value
|
Female: 35-49%
Male: 40-54% |
|
RBC Reference Value
|
Female: 4.00-5.40 X 10^6/uL
Male: 4.60-6.00 X 10^6/uL |
|
Stable RBC mass
|
1% of RBCs must be replaced daily
BM must produce ~50,000 retics/uL each day |
|
Clinical Dx of Anemia.
|
Patient hx.
Physical examination Signs/symptoms Hematologic values Other lab procedures |
|
Classic symptoms of anemia
|
Fatigue
Shortness of breath (decreased oxygen delivery) Tachychardia: increased heart rate (severe anemia) Hypotension: decreased BP (severe anemia) |
|
Factors that reflect the fall of Hb conc'n.
|
Decreased oxygen delivery to tissues
Hypovolemia (acute and marked bleeding) |
|
Physiological adaptations.
|
Increased EPO secretion by the kidneys.
Tissue hypoxia--> increased 2,3 BPG (oxygen dissociation curve shift to the reight- decreased oxygen delivery)--> inc. oxygen delivery to the tissues & inc. oxygen utilization by tissues. |
|
What does hematology analyzer can determine?
|
RBC count
Hb/Hct RBC indices |
|
RBC indices
|
Mean Cell Volume (MCV)
Mean Cell Hb (MCH) Mean Cell Hb Conc'n (MCHC) |
|
MCV
|
Normal reference range: 80-100fL
Most important of the RBC indices |
|
RBC distribution width (RDW)
|
Mathematical expression of variability within the volume distribution of the RBC population.
|
|
Anisocytosis
|
Indicates variation of RBC size.
|
|
Reticulocyte count
|
Indicate shortened survival
Appropriate response by the BM to increase RBC production. Contain residual RNA Refe. range (adult): 0.5-1.5% |
|
How to determine retic count?
|
RBC count X retic %
|
|
How to correct retic for anemia?
|
% retic X patient's Hct/44
Result of a normal Hct |
|
Reticulocyte production index (RPI)
|
Formula: Corrected retic count/maturation time
1 day= Hct of 45% 1.5 days= Hct 35% 2 days= Hct 25% 2.5 days= Hct 15% |
|
What is the expected RPI in anemic patient?
|
>2
|
|
What is the expected retic count in hemolytic anemia?
|
Appropriately elevated
|
|
Expected retic count in decreased RBC production.
|
Often decreased or inappropriately low.
|
|
Importance of retic count?
|
Helps divide anemias into decreased production or shortened RBC survival.
|
|
Blood smear examination.
|
Necessary for anemia evaluation (variations in size, shape, color, content, inclusions)
Serves as QC to verify results from automated analyzer. |
|
RBC life span?
|
120 days
Healthy individual: ~1% of "old" RBC lost daily; replaced by BM. |
|
Nutritional factors required for adequate RBC production.
|
Iron
Vit. B12 Folic acid |
|
What is erythropoeisis?
|
Marrow erythroid proliferation.
Occurs ony in BM (adult) |
|
Effective erythropoeisis
|
BM is able to produce functional RBCs that leave the marrow & supply the blood with adequate number of cells= NO ANEMIA
|
|
Ineffective erythropoesis
|
Production of progenitor cells that are defective--> reduced number of functional RBCs (ANEMIA).
Destroyed before leaving the BM Megaloblastic anemia, Thalassemia, Sideroblastic anemia |
|
Insufficient erythropoesis
|
Quantitative lack of erythroid precursors in the marrow.
Anemia due to dec. in total RBC production Fe Deficiency, EPO deficiency, Aplastic anemia, Viral infection, Suppression of RBC precursor due to marrow infiltration (tumor, leukemia) |
|
Approaches to ID the cause of anemia
|
Kinetic approach: address mechanism(s) responsible for the fall of Hb.
Morphologic Approach: categorizing anemias via alterations in RBC size & retic response. |
|
Causes of anemia
|
Decreased RBC production
Increased RBC destruction Blood loss ** May co-exist with BM suppression** |
|
Causes of reduced RBC production
|
DNA synthesis (megaloblastic anemia
HSC proliferation (aplastic anemia) Hb synthesis: Fe deficiency BM suppression (chemo) |
|
RBC life span <100 days
|
Hemolysis may not be anemia
|
|
Hemolytic anemia
|
Develops when BM unable to keep up with the need to replace >5% of the RBC mass/day, corresponding to a RNC survival of about 20 days.
|
|
Causes of increased RBC destruction (INtravascular abnormalities)
|
Membrane defects (H. spherocytosis)
Enzyme deficiency (G6PD) Globin Defects(Hemoglobinopathies) PNH (cell surface protein deficiency) |
|
Increased RBC destruction/loss (extravascular abnormalities)
|
Mechanical (MAHA- TTP, HUS)
Infection (malaria, babesia) Chemical/physical agents (burns, drugs) Immune mediated (transfusion) |
|
Blood loss (most common cause of anemia)--> loss of iron contained in these cells--> iron deficiency
|
Occult bleeding (ulcer, GI bleed, carcinoma)
Obvious bleeding (trauma, menorrhagia) |
|
Useful tests for evaluation of anemia
|
CBC
RNC indices (esp. MCV) RDW Peripheral blood smear Reticulocyte count |
|
Microcytes
|
<6um in diameter
MCV < 80fL |
|
Macrocytes
|
>8um in diameter
MCV > 100fL |
|
Hypochromic
|
MCHC < 32 g/dL
|
|
Hyperchromic
|
MCHC > 36 g/dL
|
|
Microcytic anemia
|
Caused by conditions that result in Hb synthesis reduction
Reduced Fe availability, reduced heme synthesis, reduced globin production |
|
Microcytic anemia: possible pathology
|
Fe deficiency (most common cause)
Thalassemia (deficiency in globin synthesis) Sideroblastic anemia (heme synthesis deficiency) Anemia of chronic dz (inability to use iron) Lead poisoning (heme synthesis deficiency) |
|
Types of anemia
|
Microcytic/Hypochromic anemia
Macrocytic/Normochromic anemia Normocytic/Normochromic anemia |
|
Microcytic/Hypochromic anemia
|
MCV is less than 80 fL
MCHC is less than 32 g/dL(reference range = 32 – 36 g/dL) Small RBCs with increased central pallor |
|
Macrocytic/Normochromic Anemias
|
MCV greater than 100 fL and MCHC within reference range (32 – 36 g/dL)
RBCs appear macrocytic May be megaloblastic or non-megaloblastic |
|
Megaloblastic Anemias
|
Interefere DNA synthesis
Asynchronous maturation Vitamin B12/folate deficiency; myelodysplasia (MDS) Oval macrocytes, large nRBC precursors, hypersegmented neutrophils MCV > 115fL |
|
Non- Megaloblastic Anemias
|
Round macrocytes
Related to membrane changes (disrupting cholesterol:PL ratio) Seen in chronic liver dz Rare MCV > 115fL |
|
Artifactual cause of megaloblastic anemia
|
Agglutination
|
|
Normocytic/Normochromic Anemias
|
MCV of 80 – 100 fL
MCHC of 32 – 36 g/dL Renal dz (reduced EPO), aplastic anemia, splenomegaly, infections. |
|
What does increased retic count mean?
|
BM trying to compensate by increasing production of RBCs
Most often elevated in hemolytic anemia |
|
RDW relationship to types of anemia
|
MCV low; RDW normal (microcytic; homogeneous)
Thalassemia MCV low; RDW high (microcytic; heterogeneous) Fe deficiency MCV high; RDW high (macrocytic; heterogeneous) Vitamin B12/folate deficiency MCV normal; RDW high (normocytic; heterogenous Anemic hemoglobinopathy (sickle cell anemia) |